0001709628 2025-01-01 2025-03-31 0001709628 us-gaap:CommonClassAMember 2025-04-30 0001709628 us-gaap:CommonClassBMember 2025-04-30 0001709628 2025-03-31 0001709628 2024-12-31 0001709628 us-gaap:CommonClassAMember 2025-03-31 0001709628 us-gaap:CommonClassAMember 2024-12-31 0001709628 us-gaap:CommonClassBMember 2025-03-31 0001709628 us-gaap:CommonClassBMember 2024-12-31 0001709628 2024-01-01 2024-03-31 0001709628 us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0001709628 us-gaap:CommonClassBMember 2025-01-01 2025-03-31 0001709628 us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001709628 us-gaap:CommonClassBMember 2024-01-01 2024-03-31 0001709628 CSAI:ClassACommonStockMember 2024-12-31 0001709628 CSAI:ClassBCommonStockMember 2024-12-31 0001709628 us-gaap:PreferredStockMember 2024-12-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001709628 us-gaap:RetainedEarningsMember 2024-12-31 0001709628 CSAI:ClassACommonStockMember 2023-12-31 0001709628 CSAI:ClassBCommonStockMember 2023-12-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001709628 us-gaap:RetainedEarningsMember 2023-12-31 0001709628 2023-12-31 0001709628 CSAI:ClassACommonStockMember 2025-01-01 2025-03-31 0001709628 CSAI:ClassBCommonStockMember 2025-01-01 2025-03-31 0001709628 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001709628 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001709628 CSAI:ClassACommonStockMember 2024-01-01 2024-03-31 0001709628 CSAI:ClassBCommonStockMember 2024-01-01 2024-03-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001709628 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001709628 CSAI:ClassACommonStockMember 2025-03-31 0001709628 CSAI:ClassBCommonStockMember 2025-03-31 0001709628 us-gaap:PreferredStockMember 2025-03-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001709628 us-gaap:RetainedEarningsMember 2025-03-31 0001709628 CSAI:ClassACommonStockMember 2024-03-31 0001709628 CSAI:ClassBCommonStockMember 2024-03-31 0001709628 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001709628 us-gaap:RetainedEarningsMember 2024-03-31 0001709628 2024-03-31 0001709628 2024-10-23 2024-10-24 0001709628 CSAI:VisionfulAndInfrastructureProvingGroundsMember 2023-12-30 2023-12-31 0001709628 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001709628 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001709628 CSAI:RegulationAEquityFinancingsMember us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0001709628 CSAI:RegulationAEquityFinancingsMember CSAI:WarrantsMember 2025-01-01 2025-03-31 0001709628 CSAI:RegulationAEquityFinancingsMember 2025-01-01 2025-03-31 0001709628 CSAI:Series1EquityFinancingMember CSAI:Series1ConvertiblePreferredStockMember CSAI:SecuritiesPurchaseAgreementMember 2024-11-24 2024-11-25 0001709628 CSAI:Series1EquityFinancingMember CSAI:Series1ConvertiblePreferredStockMember CSAI:SecuritiesPurchaseAgreementMember 2024-11-25 0001709628 CSAI:Series1EquityFinancingMember us-gaap:CommonClassAMember CSAI:SecuritiesPurchaseAgreementMember 2024-11-24 2024-11-25 0001709628 CSAI:Series1EquityFinancingMember CSAI:SecuritiesPurchaseAgreementMember 2024-11-24 2024-11-25 0001709628 CSAI:Series2EquityFinancingMember CSAI:Series2ConvertiblePreferredStockMember CSAI:SecondSecuritiesPurchaseAgreementMember 2025-03-20 2025-03-21 0001709628 CSAI:Series2EquityFinancingMember CSAI:Series2ConvertiblePreferredStockMember CSAI:SecondSecuritiesPurchaseAgreementMember 2025-03-21 0001709628 CSAI:Series2EquityFinancingMember CSAI:Series2ConvertiblePreferredStockMember CSAI:SecondSecuritiesPurchaseAgreementMember 2025-03-24 2025-03-25 0001709628 CSAI:Series2EquityFinancingMember CSAI:SecondSecuritiesPurchaseAgreementMember 2025-03-20 2025-03-21 0001709628 CSAI:StreetervilleMember CSAI:Series1PreferredStockMember 2025-01-01 2025-03-31 0001709628 CSAI:StreetervilleMember us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0001709628 CSAI:Price450Member 2024-12-31 0001709628 CSAI:Price720Member 2024-12-31 0001709628 CSAI:Price900Member 2024-12-31 0001709628 CSAI:Price450Member 2025-01-01 2025-03-31 0001709628 CSAI:Price720Member 2025-01-01 2025-03-31 0001709628 CSAI:Price900Member 2025-01-01 2025-03-31 0001709628 CSAI:Price450Member 2025-03-31 0001709628 CSAI:Price720Member 2025-03-31 0001709628 CSAI:Price900Member 2025-03-31 0001709628 CSAI:BentleyMember 2020-02-19 2020-02-20 0001709628 CSAI:BentleyMember 2020-02-20 0001709628 CSAI:BentleyMember 2025-03-31 0001709628 2023-12-30 2024-01-02 0001709628 us-gaap:OperatingSegmentsMember CSAI:SurveillanceSegmentMember 2025-01-01 2025-03-31 0001709628 us-gaap:OperatingSegmentsMember CSAI:SurveillanceSegmentMember 2024-01-01 2024-03-31 iso4217:USD shares iso4217:USD shares pure false --12-31 Q1 2025 0001709628

10-Q true 2025-03-31 false 001-42494 CLOUDASTRUCTURE, INC. DE 87-0690564 228 Hamilton Rd. Palo Alto CA 94301 650 644-4160 Class A Common Stock CSAI NASDAQ Yes Yes Non-accelerated Filer true true false false 16234286 487677

6897000

52000

537000

196000

265000

249000

203000

38000

7902000

535000

96000

80000

7998000

615000

461000

629000

83000 0

566000

489000

1110000

1118000

1110000

1118000

0.0001

250000000

15423725

14020543

2000

1000

0.0001

100000000

487678

571011

0.0001

150000

8285

50254000

40351000

-43369000

-40856000

6887000

-503000

7998000

615000

738000

237000

407000

253000

330000

-17000

713000

334000

606000

354000

811000

519000

636000

397000

2766000

1603000

-2436000

-1620000

9000

43000

83000 -0 2000 -0

-0

140000

-2513000

-1717000

-0.00017

-0.00012

14020543

1000

571011

40351000

-40857000

-503000

1403182 -83334 -0.0 8285 0.0 9276000 9276000

627000

-2513000

15423725

1000

487677

-0

8285

50254000

-43369000

6887000

13804788

8000

753857

38994000

-34321000

4682000

116667 -79388

278000

-1717000

13921455

8000

674469

39272000

-36038000

3242000

-2513000

-1717000

15000

19000

627000

278000

341000

-186000

182000

-52000

-167000

111000

-39000

77000

91000

-2484000

-1019000

30000

9000

-0

-30000

-9000

10750000

-83000 -0 1474000 -0

9359000

6845000

-1028000

52000

4042000

6897000

3013000

<p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z8G5fkXiLpYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note 1 – Nature of Operations Cloudastructure, Inc. (“Cloudastructure,” “we,” “us,” “our” or the “Company”) was formed on March 28, 2003, as a corporation organized under the laws of the State of Delaware and is headquartered in Palo Alto, California. We are a technology service provider that focuses on intelligent devices and software for physical security applications. Since inception, we have relied primarily on financing activities, including an offering under Regulation A of the Securities Act of 1933, as amended (the “Securities Act”), and the sale of preferred stock, to fund our operations.

Note 2 – Summary of Significant Accounting Policies Basis of Presentation The accounting and reporting policies of the Company conform to generally accepted accounting principles in the United States of America (“U.S. GAAP”). The unaudited condensed financial statements included within this report have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading. The unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes for the year ended December 31, 2024 included in our Annual Report on Form 10-K. In the opinion of management, the accompanying unaudited condensed financial statements contain all the adjustments necessary to present fairly our financial condition as of March 31, 2025 and December 31, 2024, and the results of operations for the three-month periods ended March 31, 2025 and 2024. The results of operations for the three-month periods ended March 31, 2025 are not necessarily indicative of the results to be expected for the full year. Reverse Stock Split On October 24, 2024, we effected a 1-for-6 reverse stock split of all classes of our issued and outstanding capital stock (the “Reverse Stock Split”). All share and per share information is presented after giving effect to the Reverse Stock Split retrospectively for all periods presented. For additional information about the Reverse Stock Split, see Note 6, Reverse Stock Split. Emerging Growth Company Status We are an “emerging growth company,” as defined in the Jump Start Our Business Startups Act of 2012 (“JOBS Act”). Under Section 107 of the JOBS Act, emerging growth companies are permitted to use an extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards that have different effective dates for public and private companies. We have elected to use the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company, or (ii) affirmatively and irrevocably opt out of the extended transition period provided in Section 7(a)(2)(B). By electing to extend the transition period for complying with new or revised accounting standards, our financial statements may not be comparable to the financial statements of companies that comply with public company effective dates. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the footnotes thereto. Actual results could differ from those estimates. Risks and Uncertainties We have a limited operating history. Our business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond our control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn or otherwise, inflation, changes in regulations or restrictions on imports, tariffs, competition or changes in consumer taste. These adverse conditions could affect our financial condition and our results of operations. Cash and Cash Equivalents We consider short-term, highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Cash consists of funds held in our checking account. We maintain our cash with a major financial institution located in the United States, which we believe to be creditworthy. The Federal Deposit Insurance Corporation insures balances up to $250,000, but at times we may maintain balances in excess of the federally insured limits. Receivables and Credit Policy Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. We routinely assess our outstanding accounts receivable and recorded a reserve for estimated uncollectible accounts of $0 and $5,816 at March 31, 2025, and December 31, 2024, respectively. Sales Taxes Various states impose a sales tax on our sales to non-exempt customers. We collect the sales tax from customers and remit the entire amount to each respective state. Our accounting policy is to exclude the tax collected and remitted to the states from revenue and cost of sales. Property and Equipment Property and equipment are recorded at cost if the expenditure exceeds $2,500. Expenditures for renewals and improvements that significantly add to the productive capacity or extend the useful life of an asset are capitalized. Expenditures for maintenance and repairs are expensed as incurred. When equipment is retired or sold, the cost and related accumulated depreciation are eliminated from the balance sheet accounts and the resultant gain or loss is reflected in income. Depreciation is provided using the straight-line method, based on useful lives of the assets, which range from three to five years depending on the asset type. We review the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition, and other economic factors. Segment Reporting Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (the “CODM”) in deciding how to allocate resources and assess performance. We have one reportable segment focused on cloud-based AI video surveillance and remote guarding security services. Our CODM, who is our Chief Executive Officer, manages operations on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. For additional information on our segment reporting, see Note 7, Segment Reporting. Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When fair value measurements are used, valuation techniques should maximize the use of observable inputs and minimize the use of unobservable inputs. U.S. GAAP has established a fair value hierarchy which prioritizes the valuation inputs into three broad levels. Level 1 inputs consist of quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the related asset or liability. Level 3 inputs are unobservable inputs related to the asset or liability. Income Taxes We determine deferred income taxes using the liability (or balance sheet) method. Under this method, the net deferred tax asset or liability is based on the tax effects of the differences between the book and tax bases of assets and liabilities, and enacted changes in tax rates and laws are recognized in the period in which they occur. Deferred income tax expense results from changes in deferred tax assets and liabilities between periods. Deferred tax assets are reduced by a valuation allowance if, based on the weight of evidence available, it is more likely than not that some portion or all of a deferred tax asset will not be realized. We have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income tax audit in any taxing jurisdiction. Revenue Recognition We recognize revenue when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract and (v) recognize revenue when (or as) the entity satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Revenue from subscription contracts with customers is recognized ratably over the period that commences on the subscription start date and ending on the date the subscription term expires. Revenue from door and video services is generally recognized at the completion of the professional services. Revenue from sales hardware is generally recognized at time of delivery. Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of purchase price over the fair value of identifiable net assets of businesses acquired. Our indefinite-lived intangible asset consists of assets acquired from Visionful Holding Inc. (“Visionful”) and in connection with our acquisition of Infrastructure Proving Grounds (“IPG”). We assess goodwill for impairment annually in the fourth quarter, or more frequently if events or circumstances indicate a potential impairment. During the fourth quarter of 2023, following a thorough assessment of goodwill for impairment, management determined that goodwill attributed to Visionful and IPG had become impaired due to underutilization of the acquired assets in revenue generation and on December 31, 2023, a non-cash loss on impairment was recorded reflecting goodwill impairment charges totaling $<span id="xdx_908_eus-gaap--GoodwillImpairmentLoss_pn4n6_c20231230__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--VisionfulAndInfrastructureProvingGroundsMember_zHkxf1RhFNg8" title="Goodwill impairment">1.67 million. Despite this impairment, the technology acquired remains the property of Cloudastructure and retains potential for future utilization. Liquidity Our future needs for liquidity will depend on a variety of factors, including, without limitation, our ability to generate cash flows from operations and the timing and availability of net proceeds from any future financing activities that we may conduct. Economic uncertainty, fluctuating interest rates, market volatility, slowdowns in transaction volume, delays in financings from banks and other lenders and other negative trends may, in the future, adversely impact our ability to timely access potential sources of liquidity. If we are unable to raise additional capital when desired, or on terms that are acceptable to us, our business, financial condition and results of operations could be adversely affected. On November 25, 2024, we entered into a Securities Purchase Agreement (the “Equity Financing”) with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”), upon the closing of which we will issue and sell to Streeterville $6,300,000 of newly designated Series 1 Convertible Preferred Stock, par value $0.0001 per share (the “Series 1 Preferred”) and 720,000 pre-delivery shares. We also entered into an Equity Purchase Agreement (the “Equity Purchase Agreement” or “Equity Line”) with Atlas Sciences, LLC, a Utah limited liability company (“Atlas”), which provides that, upon the terms and subject to the conditions and limitations set forth therein, Atlas will purchase up to an aggregate of $50,000,000 of our Class A common stock, par value $0.0001 per share (the “Class A common stock”), over the 24-month term of the Equity Line. For additional details regarding the Equity Financing and Equity Line, see Note 8 – Subsequent Events. Our ability to continue as a going concern is dependent on our ability to further implement our business plan. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above. We believe that upon closing the Equity Financing and the Equity Line, together with our cash on hand and anticipated cash flows from operations are sufficient to address any going concern uncertainties and will be sufficient to meet our liquidity and capital resource requirements to ensure that we are able to meet our obligations and continue operations for at least one year from the issuance date of these financial statements. Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, and requires single reporting entities to comply with the expanded reportable segment disclosures outlined in the ASU. The expanded reportable segment disclosures are intended to enhance certain disclosures surrounding significant segment expenses. This standard became effective for the Company for the annual reporting period ended December 31, 2024, using the retrospective method. The adoption of this standard resulted in additional disclosure but did not have a material impact on our financial position or results of operations. See Note 7, Segment Reporting, for our updated segment presentation. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”). ASU 2023-09 is effective for public entities for fiscal years beginning after December 15, 2024, and interim periods in fiscal years beginning after December 15, 2025, and establishes new income tax requirements in addition to modifying and eliminating certain existing requirements. Under ASU 2023-09, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation and further disaggregate income taxes paid. The Company is currently evaluating the impact of the new standard on our financial statements.

Basis of Presentation The accounting and reporting policies of the Company conform to generally accepted accounting principles in the United States of America (“U.S. GAAP”). The unaudited condensed financial statements included within this report have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading. The unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes for the year ended December 31, 2024 included in our Annual Report on Form 10-K. In the opinion of management, the accompanying unaudited condensed financial statements contain all the adjustments necessary to present fairly our financial condition as of March 31, 2025 and December 31, 2024, and the results of operations for the three-month periods ended March 31, 2025 and 2024. The results of operations for the three-month periods ended March 31, 2025 are not necessarily indicative of the results to be expected for the full year.

Reverse Stock Split On October 24, 2024, we effected a 1-for-6 reverse stock split of all classes of our issued and outstanding capital stock (the “Reverse Stock Split”). All share and per share information is presented after giving effect to the Reverse Stock Split retrospectively for all periods presented. For additional information about the Reverse Stock Split, see Note 6, Reverse Stock Split.

1-for-6 reverse stock split

Emerging Growth Company Status We are an “emerging growth company,” as defined in the Jump Start Our Business Startups Act of 2012 (“JOBS Act”). Under Section 107 of the JOBS Act, emerging growth companies are permitted to use an extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards that have different effective dates for public and private companies. We have elected to use the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company, or (ii) affirmatively and irrevocably opt out of the extended transition period provided in Section 7(a)(2)(B). By electing to extend the transition period for complying with new or revised accounting standards, our financial statements may not be comparable to the financial statements of companies that comply with public company effective dates.

Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the footnotes thereto. Actual results could differ from those estimates.

Risks and Uncertainties We have a limited operating history. Our business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond our control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn or otherwise, inflation, changes in regulations or restrictions on imports, tariffs, competition or changes in consumer taste. These adverse conditions could affect our financial condition and our results of operations.

Cash and Cash Equivalents We consider short-term, highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Cash consists of funds held in our checking account. We maintain our cash with a major financial institution located in the United States, which we believe to be creditworthy. The Federal Deposit Insurance Corporation insures balances up to $250,000, but at times we may maintain balances in excess of the federally insured limits.

Receivables and Credit Policy Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. We routinely assess our outstanding accounts receivable and recorded a reserve for estimated uncollectible accounts of $0 and $5,816 at March 31, 2025, and December 31, 2024, respectively.

5816

Sales Taxes Various states impose a sales tax on our sales to non-exempt customers. We collect the sales tax from customers and remit the entire amount to each respective state. Our accounting policy is to exclude the tax collected and remitted to the states from revenue and cost of sales.

Property and Equipment Property and equipment are recorded at cost if the expenditure exceeds $2,500. Expenditures for renewals and improvements that significantly add to the productive capacity or extend the useful life of an asset are capitalized. Expenditures for maintenance and repairs are expensed as incurred. When equipment is retired or sold, the cost and related accumulated depreciation are eliminated from the balance sheet accounts and the resultant gain or loss is reflected in income. Depreciation is provided using the straight-line method, based on useful lives of the assets, which range from three to five years depending on the asset type. We review the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition, and other economic factors.

Segment Reporting Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (the “CODM”) in deciding how to allocate resources and assess performance. We have one reportable segment focused on cloud-based AI video surveillance and remote guarding security services. Our CODM, who is our Chief Executive Officer, manages operations on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. For additional information on our segment reporting, see Note 7, Segment Reporting.

Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. When fair value measurements are used, valuation techniques should maximize the use of observable inputs and minimize the use of unobservable inputs. U.S. GAAP has established a fair value hierarchy which prioritizes the valuation inputs into three broad levels. Level 1 inputs consist of quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the related asset or liability. Level 3 inputs are unobservable inputs related to the asset or liability.

Income Taxes We determine deferred income taxes using the liability (or balance sheet) method. Under this method, the net deferred tax asset or liability is based on the tax effects of the differences between the book and tax bases of assets and liabilities, and enacted changes in tax rates and laws are recognized in the period in which they occur. Deferred income tax expense results from changes in deferred tax assets and liabilities between periods. Deferred tax assets are reduced by a valuation allowance if, based on the weight of evidence available, it is more likely than not that some portion or all of a deferred tax asset will not be realized. We have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income tax audit in any taxing jurisdiction.

Revenue Recognition We recognize revenue when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract and (v) recognize revenue when (or as) the entity satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Revenue from subscription contracts with customers is recognized ratably over the period that commences on the subscription start date and ending on the date the subscription term expires. Revenue from door and video services is generally recognized at the completion of the professional services. Revenue from sales hardware is generally recognized at time of delivery.

Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of purchase price over the fair value of identifiable net assets of businesses acquired. Our indefinite-lived intangible asset consists of assets acquired from Visionful Holding Inc. (“Visionful”) and in connection with our acquisition of Infrastructure Proving Grounds (“IPG”). We assess goodwill for impairment annually in the fourth quarter, or more frequently if events or circumstances indicate a potential impairment. During the fourth quarter of 2023, following a thorough assessment of goodwill for impairment, management determined that goodwill attributed to Visionful and IPG had become impaired due to underutilization of the acquired assets in revenue generation and on December 31, 2023, a non-cash loss on impairment was recorded reflecting goodwill impairment charges totaling $<span id="xdx_908_eus-gaap--GoodwillImpairmentLoss_pn4n6_c20231230__20231231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--VisionfulAndInfrastructureProvingGroundsMember_zHkxf1RhFNg8" title="Goodwill impairment">1.67 million. Despite this impairment, the technology acquired remains the property of Cloudastructure and retains potential for future utilization.

1670000

Liquidity Our future needs for liquidity will depend on a variety of factors, including, without limitation, our ability to generate cash flows from operations and the timing and availability of net proceeds from any future financing activities that we may conduct. Economic uncertainty, fluctuating interest rates, market volatility, slowdowns in transaction volume, delays in financings from banks and other lenders and other negative trends may, in the future, adversely impact our ability to timely access potential sources of liquidity. If we are unable to raise additional capital when desired, or on terms that are acceptable to us, our business, financial condition and results of operations could be adversely affected. On November 25, 2024, we entered into a Securities Purchase Agreement (the “Equity Financing”) with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”), upon the closing of which we will issue and sell to Streeterville $6,300,000 of newly designated Series 1 Convertible Preferred Stock, par value $0.0001 per share (the “Series 1 Preferred”) and 720,000 pre-delivery shares. We also entered into an Equity Purchase Agreement (the “Equity Purchase Agreement” or “Equity Line”) with Atlas Sciences, LLC, a Utah limited liability company (“Atlas”), which provides that, upon the terms and subject to the conditions and limitations set forth therein, Atlas will purchase up to an aggregate of $50,000,000 of our Class A common stock, par value $0.0001 per share (the “Class A common stock”), over the 24-month term of the Equity Line. For additional details regarding the Equity Financing and Equity Line, see Note 8 – Subsequent Events. Our ability to continue as a going concern is dependent on our ability to further implement our business plan. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above. We believe that upon closing the Equity Financing and the Equity Line, together with our cash on hand and anticipated cash flows from operations are sufficient to address any going concern uncertainties and will be sufficient to meet our liquidity and capital resource requirements to ensure that we are able to meet our obligations and continue operations for at least one year from the issuance date of these financial statements.

Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, and requires single reporting entities to comply with the expanded reportable segment disclosures outlined in the ASU. The expanded reportable segment disclosures are intended to enhance certain disclosures surrounding significant segment expenses. This standard became effective for the Company for the annual reporting period ended December 31, 2024, using the retrospective method. The adoption of this standard resulted in additional disclosure but did not have a material impact on our financial position or results of operations. See Note 7, Segment Reporting, for our updated segment presentation. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”). ASU 2023-09 is effective for public entities for fiscal years beginning after December 15, 2024, and interim periods in fiscal years beginning after December 15, 2025, and establishes new income tax requirements in addition to modifying and eliminating certain existing requirements. Under ASU 2023-09, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation and further disaggregate income taxes paid. The Company is currently evaluating the impact of the new standard on our financial statements.

Note 3 – Basic and Diluted Loss Per Share The number of shares used to calculate basic and diluted loss per share for the three-month periods ended March 31, 2025, and 2024 were as follows: <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zqv7Vp1So2Vi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basic and Diluted Loss Per Share (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of calculate basic and diluted loss per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Class A common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zrh3eO8nsmFd" title="Number of shares outstanding, basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zP9SsuYkpw49" title="Number of shares outstanding, diluted">15,423,725</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zA3MJYsu3c4i" title="Number of shares outstanding, basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHEd3oVn2Iik" title="Number of shares outstanding, diluted">13,921,455</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class B common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPqrzerfyM36" title="Number of shares outstanding, basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTUZjCGgf8Di" title="Number of shares outstanding, diluted">487,678</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPmObq4Ejs1h" title="Number of shares outstanding, basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpm19GGmQCk3" title="Number of shares outstanding, diluted">674,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zxLBZ15ZWMs3" title="Number of shares outstanding, basic"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zc1IYN2CYiUk" title="Number of shares outstanding, diluted">8,285</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_d0_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zmk45YGegGte" title="Number of shares outstanding, basic"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_d0_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zn6E9Lu1vK95" title="Number of shares outstanding, diluted">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,919,688</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,595,924</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> For the three months ended March 31, 2025 and 2024, approximately 18.1 million and 13.6 million shares, respectively, issuable upon the exercise or conversion of stock options, convertible notes, and warrants outstanding were excluded from the calculation of diluted loss per share because such amounts were antidilutive.

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zqv7Vp1So2Vi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basic and Diluted Loss Per Share (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of calculate basic and diluted loss per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Class A common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zrh3eO8nsmFd" title="Number of shares outstanding, basic"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zP9SsuYkpw49" title="Number of shares outstanding, diluted">15,423,725</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zA3MJYsu3c4i" title="Number of shares outstanding, basic"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHEd3oVn2Iik" title="Number of shares outstanding, diluted">13,921,455</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class B common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPqrzerfyM36" title="Number of shares outstanding, basic"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTUZjCGgf8Di" title="Number of shares outstanding, diluted">487,678</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPmObq4Ejs1h" title="Number of shares outstanding, basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpm19GGmQCk3" title="Number of shares outstanding, diluted">674,469</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zxLBZ15ZWMs3" title="Number of shares outstanding, basic"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zc1IYN2CYiUk" title="Number of shares outstanding, diluted">8,285</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_d0_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zmk45YGegGte" title="Number of shares outstanding, basic"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_d0_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zn6E9Lu1vK95" title="Number of shares outstanding, diluted">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,919,688</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,595,924</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

15423725

13921455

487678

674469

8285

15919688

14595924

18100000

13600000

Note 4 – Share Capital Regulation A Equity Financings Between 2020 and 2023, the Company sold units consisting of two shares of Class A common stock and one warrant to purchase one share of Class A common stock pursuant to Regulation A under the Securities Act (“Regulation A”). The warrants were immediately exercisable and expired 18 months from the date of issuance. Pursuant to these Regulation A offerings, the Company issued a total of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_pn5n6_c20250101__20250331__us-gaap--SecuritiesFinancingTransactionAxis__custom--RegulationAEquityFinancingsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z1YRYykT5flg" title="Number of shares issued">12.1 million shares of Class A common stock and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesOther_pn5n6_c20250101__20250331__us-gaap--SecuritiesFinancingTransactionAxis__custom--RegulationAEquityFinancingsMember__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_z4tyodYaUoK8" title="Number of shares issued">5.3 million warrants for aggregate gross proceeds of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueOther_pn5n6_c20250101__20250331__us-gaap--SecuritiesFinancingTransactionAxis__custom--RegulationAEquityFinancingsMember_zvkGmKuTCvh2" title="Aggregate gross proceeds from stock issuance">38.9 million. During the three months ended March 31, 2024, 1,459,730 warrants were exercised and 3,761,385 warrants expired, leaving 40,856 warrants outstanding as of March 31, 2024. During the three months ended March 31, 2025, no warrants were exercised and 4,317 warrants expired, leaving no warrants outstanding as of March 31, 2025. The following table is a summary of the outstanding Class A common stock warrants at December 31, 2024 and March 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zThFmE5rV0j3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Capital (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of warrant activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $4.50</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $7.20</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $9.00</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zj9ecTPV4jwd" title="Warrants outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">4,317</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued during first quarter 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_z1EdJ08FFqF" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zeNFh9iNJ8Zd" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zCYTLZ2wspXc" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expired during first quarter 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zZZl5amw3cG6" title="Warrants expired, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zsTOMTWvuX5e" title="Warrants expired, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zD4DsrExE5Lc" title="Warrants expired, shares">15,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331_zNunV0f5VV8e" title="Warrants expired, shares">4,317</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Exercised during first quarter 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zQJKibAK6M1h" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zfINzrI7umrf" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zsJGtELpMqtk" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331_zqs0M67HENM9" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zIzqswLgqz2i" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zbmkc8h2jXUj" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zzTwAyvbBWqa" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> First Quarter 2025 Equity Financings On November 25, 2024, we entered into a Securities Purchase Agreement, as subsequently amended on January 16, 2025, January 29, 2025, and February 14, 2025 (as amended, the “Series 1 Equity Financing”) with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”), pursuant to which we issued and sold <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pip0_c20241124__20241125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series1EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series1ConvertiblePreferredStockMember_z5xDClJqDw3f" title="Number of shares sold">6,300 shares of our Series 1 Convertible Preferred Stock, par value $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pip0_c20241125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series1EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series1ConvertiblePreferredStockMember_z94RzD32i2Ui" title="Sale of stock price">0.0001 per share (the “Series 1 Preferred”), and <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pip0_c20241124__20241125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series1EquityFinancingMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zdUkKSRn28v9" title="Number of shares sold">720,000 shares of our Class A common stock to Streeterville. The Series 1 Equity Financing closed on January 29, 2025 and resulted in aggregate gross proceeds to the Company of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20241124__20241125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series1EquityFinancingMember_zusN1j5TjBa8" title="Aggregate gross proceeds from sale of stock">6.3 million. On March 21, 2025, we entered into a second Securities Purchase Agreement (the “Series 2 Equity Financing”) with Streeterville pursuant to which we agreed to issue and sell up to $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20250320__20250321__us-gaap--TypeOfArrangementAxis__custom--SecondSecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series2EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series2ConvertiblePreferredStockMember_zQKdatmjMSo" title="Aggregate gross proceeds from sale of stock">40,000,000 of our newly designated Series 2 Convertible Preferred Stock, par value $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pip0_c20250321__us-gaap--TypeOfArrangementAxis__custom--SecondSecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series2EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series2ConvertiblePreferredStockMember_zyf1IeXHAuof" title="Sale of stock price">0.0001 per share (the “Series 2 Preferred” and, together with the Series 1 Preferred, the “Preferred Stock”) to Streeterville. On March 25, 2025, at the initial closing of the Series 2 Equity Financing (the “Closing Date”), we issued and sold <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pip0_c20250324__20250325__us-gaap--TypeOfArrangementAxis__custom--SecondSecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series2EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series2ConvertiblePreferredStockMember_z7RdkZ1D2Sx4" title="Number of shares sold">4,500 shares of Series 2 Preferred to Streeterville, for an aggregate purchase price of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20250324__20250325__us-gaap--TypeOfArrangementAxis__custom--SecondSecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series2EquityFinancingMember__us-gaap--StatementClassOfStockAxis__custom--Series2ConvertiblePreferredStockMember_zg8dMI8JMMWb" title="Aggregate gross proceeds from sale of stock">4.5 million. Pursuant to the terms of the Series 2 Equity Financing, Streeterville will also have, for a period ending on the later of <span id="xdx_901_ecustom--EquityFinancingDescription_pip0_c20250320__20250321__us-gaap--TypeOfArrangementAxis__custom--SecondSecuritiesPurchaseAgreementMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--Series2EquityFinancingMember_zSVLk4iPDDpi" title="Equity financing description">(i) two years from the Closing Date, and (ii) the date on which it no longer holds any Preferred Stock, the right, but not the obligation, to reinvest up to an additional $4,000,000 into the Company in one or more tranches (of at least $100,000) at its election (the “Reinvestment Right”). The Reinvestment Right supersedes and replaces the reinvestment right granted to Streeterville in connection with the Series 1 Equity Financing. In addition, Streeterville will have the right, for a period ending six months after it no longer holds any Preferred Stock or is not otherwise owed any obligations from us, to participate in up to 30% of the amount sold in any debt or equity financing that we consummate (the “Participation Right”). The Participation Right supersedes and replaces the participation right granted to Streeterville in connection with the Series 1 Equity Financing. During the three months ended March 31, 2025, Streeterville exercised its right to convert an aggregate of <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_pip0_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--Series1PreferredStockMember__srt--CounterpartyNameAxis__custom--StreetervilleMember_z3aTbaQMpTBi" title="Number of shares converted">2,515 shares of Series 1 Preferred into <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_pip0_c20250101__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--CounterpartyNameAxis__custom--StreetervilleMember_zePGKhOdQkH6" title="Number of shares converted">310,461 shares of Class A Common Stock. Stock-Based Compensation The following summarizes stock option activity for the three months ended March 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zfwtgr6wTf26" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Capital (Details - Option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of option activity</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price Range</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Options outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pip0_c20250101__20250331_fKDEp_zkTHwmwxJRGd" title="Number of Options outstanding, beginning balance">15,978,736</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRange_c20240101__20240331_fKDEp_zkYJMEFLyqKf" title="Exercise price range, options outstanding">0.024 - 2.70</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pip0_c20250101__20250331_fKDEp_zXGAzkpMlPl4" title="Weighted-average exercise price, options outstanding">1.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.7 - 6.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pip0_c20250101__20250331_zdcO3M8jVc47" title="Weighted-average exercise price, options granted">5.25</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.86 - 2.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pip0_c20250101__20250331_zWlX3xgydkU6" title="Weighted-average exercise price, options canceled">2.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: 10pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pip0_d0_c20250101__20250331_zl8TsHDK8jBa" title="Weighted-average exercise price, options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">16,055,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.024 - 6.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pip0_c20250101__20250331_zzIzZ7J1VnEi" title="Weighted-average exercise price, options outstanding">1.49</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Our board of directors grants options to our employees under the terms of our Amended and Restated Stock Option Plan. Granted options are exercisable into shares of the Company’s Class B common stock, vest over four years, with an initial one-year cliff vesting, and expire ten years from the date of grant. The fair value of the options was estimated on the grant date using the Black-Scholes option pricing model and relying on the following assumptions: (i) the estimated fair value of the underlying stock on the measurement date; (ii) the expected term in years; (iii) the expected volatility; and (iv) the discount rate.

12100000

5300000

38900000

1459730 3761385 40856 0 4317 0

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zThFmE5rV0j3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Capital (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of warrant activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $4.50</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $7.20</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants at Exercise Price of $9.00</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zj9ecTPV4jwd" title="Warrants outstanding, beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">15,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">4,317</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Issued during first quarter 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_z1EdJ08FFqF" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zeNFh9iNJ8Zd" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zCYTLZ2wspXc" title="Warrants issued, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Expired during first quarter 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zZZl5amw3cG6" title="Warrants expired, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zsTOMTWvuX5e" title="Warrants expired, shares">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zD4DsrExE5Lc" title="Warrants expired, shares">15,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_pip0_d0_c20250101__20250331_zNunV0f5VV8e" title="Warrants expired, shares">4,317</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Exercised during first quarter 2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zQJKibAK6M1h" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zfINzrI7umrf" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zsJGtELpMqtk" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_pip0_d0_c20250101__20250331_zqs0M67HENM9" title="Warrants exercised, shares">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price450Member_zIzqswLgqz2i" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price720Member_zbmkc8h2jXUj" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pip0_d0_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__custom--Price900Member_zzTwAyvbBWqa" title="Warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

15262

4317

0 0 15262 4317 0 0 0 0

6300

0.0001

720000

6300000

40000000

0.0001

4500

4500000

(i) two years from the Closing Date, and (ii) the date on which it no longer holds any Preferred Stock, the right, but not the obligation, to reinvest up to an additional $4,000,000 into the Company in one or more tranches (of at least $100,000) at its election (the “Reinvestment Right”).

2515

310461

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zfwtgr6wTf26" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share Capital (Details - Option activity)"> <tr style="vertical-align: bottom"> <td>Schedule of option activity</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price Range</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Options outstanding at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pip0_c20250101__20250331_fKDEp_zkTHwmwxJRGd" title="Number of Options outstanding, beginning balance">15,978,736</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRange_c20240101__20240331_fKDEp_zkYJMEFLyqKf" title="Exercise price range, options outstanding">0.024 - 2.70</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pip0_c20250101__20250331_fKDEp_zXGAzkpMlPl4" title="Weighted-average exercise price, options outstanding">1.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.7 - 6.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pip0_c20250101__20250331_zdcO3M8jVc47" title="Weighted-average exercise price, options granted">5.25</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">Canceled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.86 - 2.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pip0_c20250101__20250331_zWlX3xgydkU6" title="Weighted-average exercise price, options canceled">2.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: 10pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pip0_d0_c20250101__20250331_zl8TsHDK8jBa" title="Weighted-average exercise price, options exercised">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">16,055,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.024 - 6.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pip0_c20250101__20250331_zzIzZ7J1VnEi" title="Weighted-average exercise price, options outstanding">1.49</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

15978736

0.024 - 2.70

1.46

112500

2.7 - 6.75

5.25

35764

1.86 - 2.70

2.24

16055472

0.024 - 6.75

1.49

Note 5 – Related Party Transactions The following transactions occurred between related parties; therefore, there can be no guarantee that the terms, conditions, interest rates, or prices were transacted at an arm’s-length rate. Aircraft Lease On September 1, 2023, the Company and Cloud Transport Operations LLC (“Cloud Transport”) entered into a dry lease agreement (the “Dry Lease”) for a Cessna T210N Turbo Centurion plane. The Dry Lease allows the Company to lease the plane for $350 per hour plus insurance and maintenance costs. Rick Bentley (“Bentley”), the Company’s Founder and its Chief Executive Officer at the time the Dry Lease was signed, has an indirect ownership interest in Cloud Transport. In addition, also effective September 1, 2023, the Company and Hydro Hash, Inc. (“HH”) entered into a side agreement related to the Dry Lease, pursuant to which HH agreed, in exchange for use of the plane, to cover 40% of the insurance and maintenance costs for the plane under the Dry Lease. Mr. Bentley is the Chairman and a significant stockholder of HH. On March 25, 2025, the Company exercised its right to cancel the Dry Lease by providing 120 days notification of termination. Issuance of Shares for Note Receivable On February 20, 2020, we issued 250,000 shares of Class A common stock to Mr. Bentley in exchange for a promissory note in the principal amount of $6,000. The note receivable matures in February 2030 and bears interest at the rate of 1.86% per annum. As of March 31, 2025, this note has accrued interest totaling $571.37. Data Center Lease On January 1, 2024, we entered into a month-to-month lease agreement (the “Lease”) with HH to rent space for an additional data center. Under the terms of the Lease, we pay $1,800 per month for the rental of space, power and high-speed internet access. This is currently one-half the rate that we pay for equivalent services in our Santa Clara facility.

250000

6000

571

1800

Note 6 – Reverse Stock Split Our board of directors and stockholders each approved a 1-for-6 reverse stock split of all classes of the Company’s issued and outstanding capital stock. On October 24, 2024, we filed an amended and restated certificate of incorporation with the State of Delaware to immediately effectuate the Reverse Stock Split. All share and per share information are presented after giving effect to the Reverse Stock Split retrospectively for all periods presented.

1-for-6 reverse stock split

Note 7 – Segment Reporting We operate as one operating segment focused on cloud-based AI video surveillance and remote guarding security services. Operating segments are defined as components of an enterprise for which separate financial information is available for evaluation by the CODM in deciding how to allocate resources and assess performance. Our CODM evaluates our financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information supplemental to the information disclosed in these financial statements that is regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on net income as shown in our statement of operations. The CODM considers net income in the annual forecasting process and reviews actual results when making decisions about allocating resources. Since we operate as one operating segment, financial segment information, including profit or loss and asset information, can be found in these financial statements. <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zMudP3CSg0jf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Reporting (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td>Schedule of segment information</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--SurveillanceSegmentMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zZq4DcAirtP9" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--SurveillanceSegmentMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zhMuN91pLekl" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Surveillance Segment</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_zGJcZqfoaVB9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">738</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">237</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_z5ggY0YKg4kb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">407</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">253</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_zlJiyx9sjVG5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">Research & Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">354</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_z8Lwt7kmwbK6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Sales & Marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">519</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_zMxtC4rEWcNe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">General & Administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">713</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">334</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherNoncashExpense_zV6a2YTSkfP2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Non-Cash Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">397</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--OtherSettlementsInterest_zbws49E6iDe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">Other (settlements, interest, etc.)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">97</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 20pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SegmentNetIncomeLoss_zhvvsFCtygzh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment net income/(loss)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,513</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,717</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ReconciliationOfProfitOrLossAbstract_iB_zlNmTKzoLnbc" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AdjustmentsAndReconcilingItems_d0_zPdjqj0GCPD9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLoss_z1FzhccUvjG5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated net income/(loss)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,513</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,717</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zMudP3CSg0jf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Reporting (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td>Schedule of segment information</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--SurveillanceSegmentMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zZq4DcAirtP9" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--SurveillanceSegmentMember__srt--ConsolidationItemsAxis__us-gaap--OperatingSegmentsMember_zhMuN91pLekl" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Surveillance Segment</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_zGJcZqfoaVB9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">738</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">237</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CostOfRevenue_z5ggY0YKg4kb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Cost of Goods Sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">407</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">253</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_zlJiyx9sjVG5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">Research & Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">354</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_z8Lwt7kmwbK6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Sales & Marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">811</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">519</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GeneralAndAdministrativeExpense_zMxtC4rEWcNe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">General & Administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">713</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">334</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherNoncashExpense_zV6a2YTSkfP2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: 20pt">Non-Cash Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">636</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">397</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--OtherSettlementsInterest_zbws49E6iDe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 20pt">Other (settlements, interest, etc.)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">97</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 20pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SegmentNetIncomeLoss_zhvvsFCtygzh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Segment net income/(loss)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,513</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,717</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ReconciliationOfProfitOrLossAbstract_iB_zlNmTKzoLnbc" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Reconciliation of profit or loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AdjustmentsAndReconcilingItems_d0_zPdjqj0GCPD9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Adjustments and reconciling items</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NetIncomeLoss_z1FzhccUvjG5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Consolidated net income/(loss)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,513</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,717</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table>

738000

237000

407000

253000

606000

354000

811000

519000

713000

334000

636000

397000

77000 97000 -2513000 -1717000 0 0

-2513000

-1717000

Note 8 – Subsequent Events Equity Financings On April 11, 2025, we drew down an additional $3.0 million per the terms of the Series 2 Equity Financing. We issued and sold 3,000 shares of Series 2 Preferred to Streeterville for an aggregate purchase price of $3,000,000. This investment resulted in a reduction of Streeterville’s reinvestment right from $4,000,000 to $3,000,000. Subsequent to March 31, 2025, Streeterville exercised its right to convert an additional 3,060 shares of Series 1 Preferred into 810,561 shares of Class A Common Stock. On April 3, 2025, the Company issued Streeterville 75 shares of Series 1 Preferred in dividends and 7 shares of Series 2 Preferred in dividends. Management’s Evaluation Management has evaluated subsequent events to determine if events or transactions occurring after the balance sheet date through the date the financial statements were issued require potential adjustment to or disclosure in the financial statements and has concluded that all such events or transactions that would require recognition or disclosure have been recognized or disclosed.

false false false false